Regions Financial Corp Eli Lilly & CO Transaction History

Regions Financial Corp

$13.1 Billion
Q2 2024

A detailed history of Regions Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Regions Financial Corp holds 366,194 shares of LLY stock, worth $333 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares

366,194

Previous 375,773 2.55%

Holding current value

$333 Million

Previous $292 Million 13.41%

% of portfolio

2.53%

Previous 2.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $6.94 Million - $8.71 Million	-9,579 Reduced 2.55%	366,194 $332 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $5.75 Million - $7.7 Million	-9,717 Reduced 2.52%	375,773 $292 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $13.8 Million - $16.3 Million	-26,251 Reduced 6.38%	385,490 $225 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $1.73 Million - $2.39 Million	-3,988 Reduced 0.96%	411,741 $221 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $3.86 Million - $5.16 Million	-11,006 Reduced 2.58%	415,729 $195 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $9.41 Million - $11 Million	-30,281 Reduced 6.63%	426,735 $147 Million
Q4 2022 Feb 03, 2023	SELL	$321.55 - $374.67 $3.25 Million - $3.78 Million	-10,100 Reduced 2.16%	457,016 $167 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $2.8 Million - $3.19 Million	-9,434 Reduced 1.98%	467,116 $151 Million
Q2 2022 Jul 25, 2022	SELL	$278.73 - $327.27 $11.7 Million - $13.8 Million	-42,087 Reduced 8.11%	476,550 $155 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $704,539 - $875,563	-3,002 Reduced 0.58%	518,637 $149 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $2.09 Million - $2.6 Million	-9,301 Reduced 1.75%	521,639 $144 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $9.23 Million - $11.4 Million	-41,659 Reduced 7.28%	530,940 $123 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $2.01 Million - $2.6 Million	-11,137 Reduced 1.91%	572,599 $131 Million
Q1 2021 Jun 02, 2021	SELL	$164.32 - $212.72 $1.97 Million - $2.55 Million	-12,001 Reduced 2.01%	583,736 $109 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $1.81 Million - $2.39 Million	-13,839 Reduced 2.27%	595,737 $101 Million
Q3 2020 Oct 15, 2020	SELL	$146.22 - $169.13 $4.25 Million - $4.92 Million	-29,071 Reduced 4.55%	609,576 $90.2 Million
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $2.73 Million - $3.29 Million	-20,041 Reduced 3.04%	638,647 $105 Million
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $3.9 Million - $4.82 Million	-32,726 Reduced 4.73%	658,688 $91.4 Million
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $1.19 Million - $1.47 Million	11,108 Added 1.63%	691,414 $90.9 Million
Q3 2019 Oct 24, 2019	BUY	$106.79 - $116.16 $1.47 Million - $1.6 Million	13,811 Added 2.07%	680,306 $76.1 Million
Q2 2019 Jul 19, 2019	SELL	$110.79 - $129.32 $1.37 Million - $1.59 Million	-12,324 Reduced 1.82%	666,495 $73.8 Million
Q1 2019 Apr 19, 2019	SELL	$111.31 - $131.02 $8.35 Million - $9.83 Million	-74,999 Reduced 9.95%	678,819 $88.1 Million
Q4 2018 Jan 28, 2019	SELL	$105.9 - $118.64 $6.44 Million - $7.22 Million	-60,851 Reduced 7.47%	753,818 $87.2 Million
Q3 2018 Oct 22, 2018	SELL	$85.86 - $107.31 $2.68 Million - $3.34 Million	-31,166 Reduced 3.68%	814,669 $87.4 Million
Q2 2018 Jul 26, 2018	SELL	$75.7 - $86.88 $103,254 - $118,504	-1,364 Reduced 0.16%	845,835 $72.2 Million
Q1 2018 Apr 18, 2018	SELL	$74.21 - $87.6 $28.3 Million - $33.4 Million	-381,290 Reduced 31.04%	847,199 $65.5 Million
Q4 2017 Jan 18, 2018	BUY	$81.94 - $87.89 $2.01 Million - $2.15 Million	24,471 Added 2.03%	1,228,489 $104 Million
Q3 2017 Oct 23, 2017	BUY	$77.07 - $85.54 $92.8 Million - $103 Million	1,204,018	1,204,018 $103 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Eli Lilly & CO Transaction History